Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Posiphen

    Client Email Product

    Posiphen

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    0

    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    0

    API REF. PRICE (USD / KG)

    0

    API Market Place

    0

    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    12
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Annovis Announces Publication That Supports Buntanetap's MOA in Humans
    Annovis Announces Publication That Supports Buntanetap's MOA in Humans

    https://www.globenewswire.com/news-release/2024/04/01/2855138/0/en/Annovis-Announces-Publication-That-Supports-Understanding-of-Buntanetap-s-Mechanism-of-Action-in-Humans.html

    GLOBENEWSWIRE
    01 Apr 2024
    Share Share
    Annovis Bio Provides Data update for the Ph II/III Study of Buntanetap in AD's
    Annovis Bio Provides Data update for the Ph II/III Study of Buntanetap in AD's

    https://www.globenewswire.com/news-release/2024/03/20/2849275/0/en/Annovis-Bio-Provides-Data-Announcement-Update-for-the-Phase-II-III-Study-of-Buntanetap-in-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    20 Mar 2024
    Share Share
    Annovis Bio Announces Last Patient Last Visit in the Phase II/III of Buntanetap
    Annovis Bio Announces Last Patient Last Visit in the Phase II/III of Buntanetap

    https://www.globenewswire.com//news-release/2024/02/14/2828993/0/en/Annovis-Bio-Announces-Last-Patient-Last-Visit-in-the-Phase-II-III-Study-of-Buntanetap-in-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    14 Feb 2024
    Share Share
    Annovis Announces Last Patient Last Visit in the Phase III Study of Buntanetap
    Annovis Announces Last Patient Last Visit in the Phase III Study of Buntanetap

    https://www.globenewswire.com/news-release/2023/12/05/2790799/0/en/Annovis-Bio-Announces-Last-Patient-Last-Visit-in-the-Phase-III-Study-of-Buntanetap-in-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    05 Dec 2023
    Share Share
    Annovis Bio Receives Recommendation to Continue Phase 2/3 Trial of Buntanetap
    Annovis Bio Receives Recommendation to Continue Phase 2/3 Trial of Buntanetap

    https://www.businesswire.com/news/home/20231030501881/en

    BUSINESSWIRE
    30 Oct 2023
    Share Share
    Annovis Bio Receives Excellent Safety Rating and Positive Recommendation
    Annovis Bio Receives Excellent Safety Rating and Positive Recommendation

    https://www.businesswire.com/news/home/20230620060989/en

    BUSINESSWIRE
    20 Jun 2023
    Share Share
    Annovis Bio Announces Issuance of U.S. Patent Covering Buntanetap
    Annovis Bio Announces Issuance of U.S. Patent Covering Buntanetap

    https://www.globenewswire.com/news-release/2023/04/27/2656131/0/en/Annovis-Bio-Announces-Issuance-of-U-S-Patent-Covering-the-Use-of-Lead-Drug-Candidate-Buntanetap-for-Prevention-or-Treatment-of-Disease-States-Due-to-Metal-Dis-Homeostasis-in-Health.html

    GLOBENEWSWIRE
    27 Apr 2023
    Share Share
    Annovis Announces Approval for European Union Trial Sites for PIII of Buntanetap
    Annovis Announces Approval for European Union Trial Sites for PIII of Buntanetap

    https://www.prnewswire.com/news-releases/annovis-bio-announces-approval-for-european-union-clinical-trial-sites-for-the-phase-3-study-of-buntanetap-for-the-treatment-of-parkinsons-disease-301741593.html

    PR NEWSWIRE
    08 Feb 2023
    Share Share
    Annovis Announces Patient Enrollment Update For Phase 3 Of Buntanetap
    Annovis Announces Patient Enrollment Update For Phase 3 Of Buntanetap

    https://www.prnewswire.com/news-releases/annovis-bio-announces-patient-enrollment-update-for-phase-3-study-of--buntanetap-for-the-treatment-of-parkinsons-disease-301730138.html

    PR NEWSWIRE
    25 Jan 2023
    Share Share
    Annovis Announces FDA Authorization to Proceed with Ph 2/3 Trial for Buntanetap
    Annovis Announces FDA Authorization to Proceed with Ph 2/3 Trial for Buntanetap

    https://www.prnewswire.com/news-releases/annovis-bio-announces-fda-authorization-to-proceed-with-phase-23-trial-for-buntanetap-in-alzheimers-disease-301642292.html

    PRNEWSWIRE
    06 Oct 2022
    Share Share
    Annovis Bio Announces Positive FDA Notice For Buntanetap PIII Trial In PD
    Annovis Bio Announces Positive FDA Notice For Buntanetap PIII Trial In PD

    https://www.prnewswire.com/news-releases/annovis-bio-announces-positive-fda-notice-for-buntanetap-phase-3-clinical-trial-in-parkinsons-disease-301582101.html

    PRNEWSWIRE
    07 Jul 2022
    Share Share
    Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Actio
    Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Actio

    https://www.prnewswire.com/news-releases/the-law-offices-of-frank-r-cruz-announces-the-filing-of-a-securities-class-action-on-behalf-of-annovis-bio-inc-anvs-investors-301370127.html

    PRNEWSWIRE
    07 Sep 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search